Richard J. Russell

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions

D. Ryan, A. Custovic, S. Johnston, 2019, European Respiratory Journal.

Managing Chronic Cough due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report.

L. Boulet, C. Brightling, P. Gibson, 2020, Chest.

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

Robert J. Mackenzie, Patrick M Liu, M. Haynes, 2022, The Lancet Respiratory Medicine.

Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma

C. Brightling, R. Russell, Richard J. Russell, 2016, Expert review of respiratory medicine.

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.

V. Backer, M. Braddock, Dave Singh, 2018, The Lancet. Respiratory medicine.

Effect of the interleukin-13 neutralising monoclonal antibody , tralokinumab , on eosinophilic airway inflammation in uncontrolled moderate to severe asthma ( MESOS – a randomised placebo-controlled phase 2 clinical trial )

Rekha, V. Backer, M. Braddock, 2018 .

University of Southern Denmark Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS) a multicentre, double-blind, randomised, placebo-controlled phase 2 trial

Rekha, V. Backer, M. Braddock, 2018 .

Cough and Eosinophilia.

C. Brightling, S. Diver, R. Russell, 2019, The journal of allergy and clinical immunology. In practice.

New and emerging drug treatments for severe asthma

C. Brightling, S. Diver, R. Russell, 2018, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Pathogenesis of asthma: implications for precision medicine.

C. Brightling, R. Russell, Richard J. Russell, 2017, Clinical science.

Airway smooth muscle NOX4 is upregulated and modulates ROS generation in COPD

C. Brightling, R. Russell, C. Szyndralewiez, 2016, Respiratory Research.